Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2287]

Durvalumab in novel combinations for head and neck cancer

Dr Ezra Cohen - UC San Diego Health, San Diego, USA

Durvalumab in novel combinations for head and neck cancer ( Dr Ezra Cohen - UC San Diego Health, San Diego, USA )

COMBI-AD: Dabrafenib plus trametinib in advanced melanoma

Dr Axel Hauschild - University Hospital, Schleswig-Holstein, Germany

COMBI-AD: Dabrafenib plus trametinib in advanced melanoma ( Dr Axel Hauschild - University Hospital, Schleswig-Holstein, Germany )

Checkmate 238: Adjuvant checkpoint therapy after melanoma resection

Dr Jeffrey Weber - Perlmutter Cancer Center, New York, USA

Checkmate 238: Adjuvant checkpoint therapy after melanoma resection ( Dr Jeffrey Weber - Perlmutter Cancer Center, New York, USA )

The role of tumour marker testing in early diagnosis

Dr Craig Barrington - South West Wales Cancer Centre, UK

The role of tumour marker testing in early diagnosis ( Dr Craig Barrington - South West Wales Cancer Centre, UK )

The METRIC trial of trametinib, five years on

Prof Dirk Schadendorf - Essen University Hospital, Essen, Germany

The METRIC trial of trametinib, five years on ( Prof Dirk Schadendorf - Essen University Hospital, Essen, Germany )

New strategies in melanoma care

Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands

New strategies in melanoma care ( Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands )

RANGE trial of ramucirumab for urothelial cancer

Prof Daniel Petrylak - Yale Cancer Center, New Haven, Connecticut, USA

RANGE trial of ramucirumab for urothelial cancer ( Prof Daniel Petrylak - Yale Cancer Center, New Haven, Connecticut, USA )

Adaptive TONIC trial of nivolumab combinations for breast cancer

Dr Marleen Kok - Netherlands Cancer Institute, Amsterdam, Netherlands

Adaptive TONIC trial of nivolumab combinations for breast cancer ( Dr Marleen Kok - Netherlands Cancer Institute, Amsterdam, Netherlands )

Panitumumab triplet therapy in colorectal cancer

Prof Michael Geißler - Klinikum Esslingen, Esslingen am Neckar, Germany

Panitumumab triplet therapy in colorectal cancer ( Prof Michael Geißler - Klinikum Esslingen, Esslingen am Neckar, Germany )

Long term efficacy of denosumab for giant cell bone tumours

Prof Emanuela Palmerini - Rizzoli Orthopedic Institute, Bologna, Italy

Long term efficacy of denosumab for giant cell bone tumours ( Prof Emanuela Palmerini - Rizzoli Orthopedic Institute, Bologna, Italy )

Phase Ib/II trial of combination PD-1 therapy against kidney cancer

Dr Chung-Han Lee - Memorial Sloan Kettering Cancer Center, New York, USA

Phase Ib/II trial of combination PD-1 therapy against kidney cancer ( Dr Chung-Han Lee - Memorial Sloan Kettering Cancer Center, New York, USA )

Reviewing LORELEI, mindACT and ExteNET trials in breast cancer

Prof Miguel Martin - Hospital General Universitario Gregorio Marañón, Madrid...

Reviewing LORELEI, mindACT and ExteNET trials in breast cancer ( Prof Miguel Martin - Hospital General Universitario Gregorio Marañón, Madrid, Spain )

More from ecancer